The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vanaja Kuchipudi
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.9 pts more than Nifty Microcap 250 and 5.4 pts more than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Vanaja Kuchipudi, a promoter of Jeevan Scientific Technology Limited, has acquired 6,00,000 (six lakh) convertible warrants through a preferential issue on January 2, 2026. Before this, she held 15,73,800 equity shares representing 9.93% of voting rights. After the warrant acquisition, her combined holding of shares plus warrants stands at 21,73,800 units, equal to 7.90% of the expanded voting capital and 9.28% on a fully diluted basis. The company's equity share capital grew from Rs. 15.83 crore to Rs. 19.92 crore as a result of this preferential allotment. This is a disclosure filed under Regulation 29(2) of SEBI's Takeover Regulations, 2011.
The promoter is strengthening her economic interest in the company by putting additional capital into convertible warrants, signalling confidence in the business. While the preferential issue diluted her direct shareholding percentage from 9.93% to 7.90%, her overall stake on a diluted basis is maintained, which is generally seen as a positive sign for retail investors.